AERD	aspirin-exacerbated respiratory disease
Bcl	B cell lymphoma 2
BEGM	bronchial epithelial cell growth medium
cDNA	complementary DNA
CNS	central nervous system
COX	cyclooxygenase
CRSwNP	chronic rhinosinusitis with nasal polyps
CysLT	cysteinyl leukotrienes
CysLTR1	cysteinyl leukotriene receptor 1
DMEM	Dulbecco’s modified Eagle’s medium
DNA	deoxyribonucleic acid
EC	epithelial cell
ECM	extracellular matrix
ELF	epithelial lining fluid
ELISA	enzyme-linked immune sorbent assay
EMT	epithelial-mesenchymal transition
ESCC	esophageal squamous cell carcinoma
FEV1	forced expiratory volume in 1 s
GEO	Gene Expression Omnibus
GO	Gene Ontology
GRCh38	Genome Reference Consortium Human Build 38
HETE-5	hydroxyeicosatetraenoic acid
HPGD-15	hydroxyprostaglandin dehydrogenase
HT	high-throughput
Ig E	immunoglobulin E
IHC	immunohistochemistry
LTE4	leukotriene E4
NAEC	nasal airway epithelial cells
NCBI	National Center for Biotechnology Information
N-ERD	NSAID-exacerbated respiratory disease
NNAEC	non-affected nasal area epithelial cell
NNPEC-N-ERD	nasal polyp epithelial cell
NP	nasal polyps
NPEC	nasal polyp epithelial cell
NSAID	non-steroidal anti-inflammatory drug
NSCLC	non-small cell lung cancer
Oxo-ETE	oxoicosatetraenoic acid
PBS	phosphate-buffered saline
PGE2	prostaglandin E2
RIN	RNA integrity number